Company: SYRA
Filing Date: 2025-03-11
Form Type: 10-K
Source: 0001493152-25-009873
Chunk: 277

Company: Syra Health Corp
Filing Date: 2025-03-11
Form: 10-K
Item: Item 1A
Chunk 277
---
 MSCI announced its decision to include equity securities
“with unequal voting structures” in its indices. Additionally, MSCI announced that the securities of companies exhibiting
unequal voting structures will be eligible for addition to the MSCI ACWI IMI and other relevant indexes effective March 1, 2019. Currently,
MSCI offers the MSCI World Voting Rights-Adjusted Index. This index specifically includes voting rights in the weighting criteria and
construction methodology and aims to better align constituent weights with economic rights and voting power, while continuing to represent
the performance of a broad opportunity set. The dual-class structure of our common stock may make us ineligible for inclusion in certain
indices and, as a result, mutual funds, exchange-traded funds and other investment vehicles that attempt to passively track those indices
would not invest in our Class A common stock. In addition, it is unclear what effect, if any, such policies will have on the valuations
of publicly-traded companies excluded from such indices, but it is possible that they may adversely affect valuations, as compared to
similar companies that are included. Due to the dual-class structure of our common stock, we may be excluded from certain indices and
we cannot assure you that other stock indices (including Nasdaq) will not take similar actions. Given the sustained flow of investment
funds into passive strategies that seek to track certain indices, exclusion from certain stock indices may preclude investment by many
of these funds and could make our Class A common stock less attractive to other investors. As a result, the market price of our Class
A common stock may be adversely affected.

Our
principal stockholders will continue to have significant influence over the election of our board of directors and approval of any significant
corporate actions, including any sale of the Company.

Deepika
Vuppalanchi, our Chief Executive Officer and Priya Prasad, our Chief Financial Officer and Chief Operating Officer, in the aggregate,
beneficially own 51.0% of our Class B common stock and 30.9% of our outstanding voting securities. These stockholders currently have,
and likely will continue to have, significant influence with respect to the election of our board of directors and approval or disapproval
of all significant corporate actions. The concentrated voting power of these stockholders could have the effect of delaying or preventing
an acquisition of the Company or another significant corporate transaction.

We
could be subject to securities class action litigation.

In
the past, securities class action litigation has